Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLCA: Delayed Radiotherapy in 1p/19q Codeleted Anaplastic Gliomas
NCT02444000Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2015
- Primary completion
- Oct 2022
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of lomustine, vincristine sulfate liposome injection, procarbazine in anaplastic glioma, sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2015; status: completed.
02
Drugs
lomustinevincristine sulfate liposome injectionprocarbazine
03
Conditions
anaplastic glioma
Beyond the preview
Go deeper on NCT02444000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02444000.